Efficacy, Immunogenicity, and Safety Study of a Respiratory Syncytial Virus Vaccine in Infants and Toddlers

NCT06252285 · clinicaltrials.gov ↗

PHASE3

Phase

TERMINATED

Status

6300

Enrollment

INDUSTRY

Sponsor class

Stopped Sponsor decision

Conditions

RSV Immunisation

Interventions

BIOLOGICAL: RSVt Vaccine
BIOLOGICAL: Placebo

Sponsor

Sanofi Pasteur, a Sanofi Company